-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Depreciation history and change rate from 2024 to 2025.
- BriaCell Therapeutics Corp. Depreciation for the quarter ending 31 Oct 2024 was $22,839.000.
- BriaCell Therapeutics Corp. annual Depreciation for 2025 was $91,356.000, a 33.1% increase from 2024.
Depreciation, Quarterly (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)